Sienna Biopharmaceuticals misses estimates as net losses grow

You are here: Home > Biotech > Current Article

Sienna Biopharmaceuticals misses estimates as net losses grow

By Staff Report / Thursday, March 14th, 2019 / Comments Off on Sienna Biopharmaceuticals misses estimates as net losses grow

Westlake Village-based Sienna Biopharmaceuticals reported that operating expenses rose 41 percent for its fourth quarter to $19.8 million, topping $76 million in 2018. The pre-revenue company ended the year with $48.5 million in cash and cash equivalents and raised another $21.3 million in net proceeds from a stock offering in February as it advanced clinical…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.